Page last updated: 2024-10-21

hydroxyindoleacetic acid and Respiratory Distress Syndrome, Newborn

hydroxyindoleacetic acid has been researched along with Respiratory Distress Syndrome, Newborn in 1 studies

(5-hydroxyindol-3-yl)acetic acid : A member of the class of indole-3-acetic acids that is indole-3-acetic acid substituted by a hydroxy group at C-5.

Respiratory Distress Syndrome, Newborn: A condition of the newborn marked by DYSPNEA with CYANOSIS, heralded by such prodromal signs as dilatation of the alae nasi, expiratory grunt, and retraction of the suprasternal notch or costal margins, mostly frequently occurring in premature infants, children of diabetic mothers, and infants delivered by cesarean section, and sometimes with no apparent predisposing cause.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Tóth, G1
Kerekes, A1
Almási, M1

Other Studies

1 other study available for hydroxyindoleacetic acid and Respiratory Distress Syndrome, Newborn

ArticleYear
[Hydroxyindoleactic acid excretion and respiratory distress syndrome in the 1st days of life in a premature infant].
    Acta paediatrica Academiae Scientiarum Hungaricae, 1979, Volume: 20, Issue:4

    Topics: Humans; Hydroxyindoleacetic Acid; Infant, Newborn; Infant, Premature, Diseases; Respiratory Distress

1979